Veridian Expands Respiratory Device Portfolio with Acquisition of Zewa
The acquisition strengthens Veridian Healthcare’s respiratory device offerings and expands its remote patient monitoring and telehealth product portfolio.
Tag: business news
All
Latest
All
Latest
React Health and ReactDx Announce New Mission and Vision Statements
The new statements focus on improving diagnostics and therapies for respiratory, sleep, and cardiac care.
All
Latest
FDA Recognizes Lung Infection Test for Immunocompromised Patients
The test was granted FDA Breakthrough Device status for its potential to improve the diagnosis of lung infections in immunocompromised patients.
Philips Reaches $1.1 Billion Settlement in US Respiratory Device Litigation
The company anticipates the settlement will resolve all personal injury and medical monitoring claims related to its June 2021 recall.Â
Read More
Nonin to Enhance Pulse Oximetry with Remote Monitoring Services
Nonin Medical partners with Medixine to co-develop remote digital monitoring services for more patient-centric diagnoses of chronic conditions.
Read More
Bactiguard Appoints New CEO
Christine Lind assumed the role of CEO of Bactiguard AB on April 12, 2024, according to the the Board of Bactiguard Holding AB.
Read More
Baxter Expands US Pharma Portfolio
Baxter has expanded its US pharmaceuticals portfolio by launching five injectable drugs, including Vancomycin to treat infections of methicillin-resistant staphylococci.
Read More
Dynarex Expands Resp-O2 Line with Portable Products
Dynarex adds new suite of portable respiratory solutions to its Resp-O2 product line, including a compressor for high-flow therapy, a home care portable suction unit, and more.
Read More
Federal Court Finalizes Consent Decree Against Philips RespironicsÂ
The decree mandates a recall remediation plan and production restrictions to address safety concerns following the widespread 2021 recall of CPAP and BiPAP machines.
Read More
FDA Approves Merck’s Injection for Pulmonary Arterial Hypertension
The injection on top of background therapy significantly improved exercise capacity and multiple secondary outcome measures compared to background therapy alone.
Read More
AstraZeneca Sets $35 Monthly Cap on Inhaler Costs
Starting June 1, eligible patients will pay no more than $35 per month for all AstraZeneca US inhaled respiratory medicines.
Read More
Masimo, UCHealth Partner on Telehealth
Masimo and UCHealth (Colorado) are entering into a strategic collaboration to improve the standard of patient care using the latest in virtual care and telehealth capabilities.
Read More
Medline Acquires AG Cuffill Cuff Pressure Manometer
Medline Industries announced the acquisition of the manufacturing rights and intellectual property of AG Cuffill from Hospitech Respiration Ltd.
Read More
New Unique CMS Code Assigned to React Health V+C Integrated Cough Therapy
The Centers for Medicare and Medicaid Services (CMS) has assigned a new, unique HCPCs code (E0468) exclusively to the React Health V+C Ventilator with Integrated Cough Assist Technology, according to a company announcement.
Read More
Aria CV Implants First Patient with Pulmonary Hypertension System
Aria CV Inc reports its first patient was implanted with the Gen 2 Aria CV Pulmonary Hypertension System.
Read More